PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,016.00
Bid: 1,016.00
Ask: 1,022.00
Change: -16.00 (-1.55%)
Spread: 6.00 (0.591%)
Open: 1,046.00
High: 1,046.00
Low: 1,006.00
Prev. Close: 1,032.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

23 Jul 2013 08:09

RNS Number : 9168J
CVS Group plc
23 July 2013
 

 

23 July 2013

 

CVS Group plc (the "Group")

 

Trading Update

 

The Board is pleased to announce that the results for the year ended 30 June 2013 will be in line with market expectations and will be released on Tuesday 24 September 2013.

 

Total like-for-like Group turnover for the year showed growth of 3.4%. This growth was achieved despite sales being moderately impacted by snow during January (0.2% impact) and there being one fewer trading days in the second half of 2013 compared to 2012 (0.3% impact).

 

Good organic growth has been achieved in the core veterinary practices throughout the year. The period has seen growth of over 70% in the membership of loyalty schemes which now exceed 111,900 pets compared to 65,500 at this time last year. At current run rates loyalty schemes are contributing over 9% of the total revenue from practices.

 

It is pleasing to report that there has been significant growth in the e-commerce operations. Animed Direct is currently generating some £6.7 million of annualised revenue, compared with £3.5 million at 30 June 2012 and continues to show significant growth opportunities. In addition, five on-line practice shops were opened during the year.

 

Internally funded acquisition activity has continued to play an important part in the Group's strategy. In addition to the three practices and the pet crematorium acquired in the first half of the year, four practices, Cranmore (two sites in Chester), Archway (Petersfield), Alver (three sites in and around Gosport) and Filham Park (Ivy Bridge, Devon) were acquired during the second half. These four acquisitions extend the Group's practice division's operations and the sites are an excellent geographic fit with the Group's existing surgeries. All of the acquisitions have been successfully integrated into the Group. Subsequent to the year end on 15 July 2013, Crescent (Melton Mowbray) was acquired. Based on the last financial year prior to acquisition the aggregate turnover derived from these five additional practices amounted to £8.3 million.

 

As well as small animal services, the Filham Park and Crescent practices both include some equine activities, extending our offering in this area. The Cranmore acquisition includes a referrals centre and on 1 July 2013 Professor John Innes joined us as a Referrals Director to run and expand our referrals business. John has been a leading figure in the academic and animal orthopaedic worlds for many years; most recently he has been closely involved in developing clinical services at the University of Liverpool. Not only will John bring world class experience in orthopaedics to the Group, but he will also bring experience and expertise in the development of referral services.

 

In total the Group now operates 248 veterinary practices across the UK, an on-line dispensary and 11 on-line practice shops, 5 diagnostic laboratories and 2 pet crematoria. CVS continues to be the UK's largest operator in a highly fragmented market.

 

For further enquiries please contact:

 

CVS Group plc: 01379 644 288

Simon Innes - Chief Executive

Nick Perrin - Finance Director

 

N+1 Singer 020 7496 3000

Aubrey Powell

Graeme Summers

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGMGZNNFKGFZG
Date   Source Headline
1st May 20247:00 amRNSAppointment of Non-executive Chair
30th Apr 20247:00 amRNSTotal Voting Rights
11th Apr 20245:48 pmRNSStandard form for notification of major holdings
8th Apr 20247:00 amRNSNotice of Cyber Incident
28th Mar 20244:07 pmRNSExercise of Options and Total Voting Rights
12th Mar 20248:06 amRNSResponse to CMA update
29th Feb 20247:00 amRNSExercise of Options and Total Voting Rights
29th Feb 20247:00 amRNSInterim Results
5th Feb 202411:02 amRNSStandard form for notification of major holdings
31st Jan 20247:00 amRNSExercise of Options and Total Voting Rights
29th Jan 20243:41 pmRNSPDMR Dealing
25th Jan 20247:00 amRNSHalf year Trading Update
19th Jan 20242:24 pmRNSExercise of SAYE Options and PDMR Dealing
12th Jan 20241:56 pmRNSExercise of SAYE Options and PDMR Dealing
12th Jan 20247:00 amRNSBlock Listing Interim Review
5th Jan 20242:44 pmRNSReplacement of Director/PDMR Shareholding
5th Jan 202410:25 amRNSDirector/PDMR Shareholding
29th Dec 20237:00 amRNSExercise of Options and Total Voting Rights
22nd Dec 20237:48 amRNSBlock Listing Application
30th Nov 20237:00 amRNSExercise of Options and Total Voting Rights
29th Nov 20233:43 pmRNSResult of AGM
29th Nov 20237:00 amRNSAGM Statement and Trading Update
24th Nov 20233:56 pmRNSGrant of Options under CVS Group plc
3rd Nov 20237:05 amRNSPosting of Annual Report and Notice of AGM
31st Oct 20234:46 pmRNSExercise of Options and Total Voting Rights
27th Oct 20237:00 amRNSDirectorate Change
13th Oct 20235:21 pmRNSConfirmation of dividend dates
9th Oct 20232:58 pmRNSExercise of Options, PDMR Dealing, EBT and TVR
29th Sep 20237:00 amRNSExercise of Options and Total Voting Rights
21st Sep 20237:00 amRNSFinal results for the year ended 30 June 2023
7th Sep 202310:50 amRNSResponse to CMA review into veterinary market
31st Aug 20237:00 amRNSExercise of Options and Total Voting Rights
31st Jul 20237:00 amRNSTotal Voting Rights
27th Jul 20237:00 amRNSTrading update, AU expansion and UK acquisitions
12th Jul 20237:00 amRNSBlock Listing Interim Review and TVR Update
30th Jun 20237:00 amRNSExercise of Options and Total Voting Rights
22nd Jun 20237:00 amRNSDirectorate Change
31st May 20237:00 amRNSExercise of Options and Total Voting Rights
12th May 20234:41 pmRNSStandard form for notification of major holdings
5th May 20238:53 amRNSBlock Listing Application
2nd May 20237:00 amRNSTotal Voting Rights
31st Mar 20231:39 pmRNSHolding(s) in Company
31st Mar 20237:00 amRNSTotal Voting Rights
10th Mar 202310:37 amRNSExercise of SAYE Options, PDMR Dealing and TVR
28th Feb 20237:00 amRNSExercise of Options and Total Voting Rights
24th Feb 20237:00 amRNSInterim Results
2nd Feb 20234:42 pmRNSExercise of Options and Total Voting Rights
26th Jan 20237:00 amRNSHalf year Trading Update
11th Jan 20234:31 pmRNSBlock Listing Interim Review and TVR Update
10th Jan 202312:24 pmRNSExercise of SAYE Options and PDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.